Nyxoah SA - Ordinary Shares (NYXH)
4.7100
+0.0500 (1.07%)
NASDAQ · Last Trade: Sep 18th, 3:03 PM EDT
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
By Nyxoah · Via GlobeNewswire · September 15, 2025
By Nyxoah · Via GlobeNewswire · September 5, 2025
Nyxoah Announces Upcoming Investor Events
By Nyxoah · Via GlobeNewswire · September 2, 2025
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 29, 2025
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 18, 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
By Nyxoah · Via GlobeNewswire · August 11, 2025
INSIDE INFORMATIONREGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 8, 2025
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · July 29, 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
By Nyxoah · Via GlobeNewswire · July 29, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
By Nyxoah · Via GlobeNewswire · July 28, 2025
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 27, 2025
REGULATED INFORMATIONJune 13, 2025, 7:00am CET / 1:00am ET
By Nyxoah · Via GlobeNewswire · June 13, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference
By Nyxoah · Via GlobeNewswire · May 28, 2025
By Nyxoah · Via GlobeNewswire · May 23, 2025
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 18, 2025
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · May 14, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
REGULATED INFORMATIONMay 9, 2025, 7:00am CET / 1:00am ET
By Nyxoah · Via GlobeNewswire · May 9, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
By Nyxoah · Via GlobeNewswire · May 7, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 29, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 25, 2025